Cognitive Dysfunction in Chronic Kidney Disease Patients: Time to Prevent
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · 03.01.2024
DOI: 10.71749/pkj.17 ↗Kurz gefasst
Fachartikel in der Zeitschrift Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT), erschienen am 03.01.2024. Verfasst von Ana Carina Ferreira.
Abstract (Originalsprache)
Mild cognitive impairment (MCI) is a neurocognitive deterioration of at least one of the following six cognitive domains in humans: complex attention, executive function, learning and memory, language, perceptual‑motor, and social cognition. Patients with chronic kidney disease are at an increased risk of developing this disorder, with serious implications for the patient, family, and society. In this article, we aim to increase awareness of the disorder and summarize the existing evidence on the topic.
Schlagwörter
Zitieren
APA
Ferreira, A. C. (2024). Cognitive Dysfunction in Chronic Kidney Disease Patients: Time to Prevent. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). https://doi.org/10.71749/pkj.17
Vancouver
Ferreira AC. Cognitive Dysfunction in Chronic Kidney Disease Patients: Time to Prevent. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 2024. doi:10.71749/pkj.17
BibTeX
@article{Ferreira2024,
author = {Ferreira, Ana Carina},
title = {Cognitive Dysfunction in Chronic Kidney Disease Patients: Time to Prevent},
journal = {Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)},
year = {2024},
doi = {10.71749/pkj.17}
}
EUVIMED